N	Concordance
1	motherapy with high-dose cytarabine and daunorubicin. Transplantation soon after
2	e, L-asparaginase, and an anthracycline (daunorubicin or idarubicin). Only those
3	eved with induction regimens containing daunorubicin and cytarabine with or wit
4	 cases an anthracyline antibiotic (e.g. daunorubicin, doxorubicin, or idarubicin
5	e -- Daunoxome (liposomal-encapsulated  daunorubicin) was compared with standard
6	      on in affecting the intracellular daunorubicin accumulation (IDA) and in  
7	tumors. It is unclear whether liposomal daunorubicin or liposomal doxorubicin is
8	ometry showed decreased accumulation of daunorubicin in these sublines as compar
9	 gradually increasing concentrations of daunorubicin in order to determine the m
10	sm of these studies is that the dose of daunorubicin in these randomized studies
11	 therapy). After induction therapy with daunorubicin, cytosine arabinoside (araC